Markers of the basal cell layer of prostate are effective indicators of its malignant transformation

[1]  M. Shen,et al.  Cell types of origin for prostate cancer. , 2015, Current opinion in cell biology.

[2]  J. Pringle,et al.  Plasticity of melanoma and EMT-TF reprogramming , 2013, Oncotarget.

[3]  Wai Leong Tam,et al.  The epigenetics of epithelial-mesenchymal plasticity in cancer , 2013, Nature Medicine.

[4]  J. Lachuer,et al.  A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. , 2013, Cancer cell.

[5]  Z. Werb,et al.  Roadblocks to translational advances on metastasis research , 2013, Nature Medicine.

[6]  L. Xin.  Cells of origin for cancer: an updated view from prostate cancer , 2013, Oncogene.

[7]  Sarita Gupta,et al.  Prostate Stem Cells in the Development of Benign Prostate Hyperplasia and Prostate Cancer: Emerging Role and Concepts , 2013, BioMed research international.

[8]  M. D. Lloyd,et al.  α-Methylacyl-CoA racemase (AMACR): metabolic enzyme, drug metabolizer and cancer marker P504S. , 2013, Progress in lipid research.

[9]  Hongbo Wei,et al.  Coaction of Spheroid-Derived Stem-Like Cells and Endothelial Progenitor Cells Promotes Development of Colon Cancer , 2012, PloS one.

[10]  Hans Clevers,et al.  Wnt/β-Catenin Signaling and Disease , 2012, Cell.

[11]  Y. Kanai,et al.  Overexpression of α‐methylacyl‐CoA racemase is associated with CTNNB1 mutations in hepatocellular carcinomas , 2011, Histopathology.

[12]  N. Maitland,et al.  Prostate Cancer Stem Cells: Do They Have a Basal or Luminal Phenotype? , 2011, Hormones & cancer.

[13]  Krishanu Saha,et al.  Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved Issues , 2010, Cell.

[14]  Rameen Beroukhim,et al.  An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB , 2010, Nature Medicine.

[15]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[16]  K. Leong,et al.  Generation of a prostate from a single adult stem cell , 2008, Nature.

[17]  B. Olsen,et al.  Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. , 2008, Molecular biology of the cell.

[18]  Robert A. Weinberg,et al.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.

[19]  M. D. Lloyd,et al.  α‐Methylacyl‐CoA racemase – an ‘obscure’ metabolic enzyme takes centre stage , 2008, The FEBS journal.

[20]  S. Zhang,et al.  Prostatic stromal cells derived from benign prostatic hyperplasia specimens possess stem cell like property , 2007, The Prostate.

[21]  J. Hiltunen,et al.  The catalysis of the 1,1-proton transfer by alpha-methyl-acyl-CoA racemase is coupled to a movement of the fatty acyl moiety over a hydrophobic, methionine-rich surface. , 2007, Journal of molecular biology.

[22]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[23]  O. Witte,et al.  Isolation and functional characterization of murine prostate stem cells , 2007, Proceedings of the National Academy of Sciences.

[24]  P. Humphrey,et al.  Diagnosis of adenocarcinoma in prostate needle biopsy tissue , 2007, Journal of Clinical Pathology.

[25]  T. Suda,et al.  A quantitative matrigel assay for assessing repopulating capacity of prostate stem cells. , 2005, Biochemical and biophysical research communications.

[26]  J. Hiltunen,et al.  Alpha-methylacyl-CoA racemase from Mycobacterium tuberculosis. Mutational and structural characterization of the active site and the fold. , 2005, The Journal of biological chemistry.

[27]  Michael F. Clarke,et al.  Applying the principles of stem-cell biology to cancer , 2003, Nature Reviews Cancer.

[28]  Zhong Jiang,et al.  Expression of α-methylacyl-coa racemase (p504s) in various malignant neoplasms and normal tissues: a study of 761 cases , 2003 .

[29]  D. Moscatelli,et al.  Androgens modulate the balance between VEGF and angiopoietin expression in prostate epithelial and smooth muscle cells , 2002, The Prostate.

[30]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[31]  M. Becich,et al.  The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia. , 1992, The Journal of urology.

[32]  Alexander Gheldof,et al.  Cadherins and epithelial-to-mesenchymal transition. , 2013, Progress in molecular biology and translational science.

[33]  N. Petrov,et al.  [Production and characteristics of the growth and marker properties of mesenchymal stem cells of urinary bladder]. , 2013, Zhurnal evoliutsionnoi biokhimii i fiziologii.

[34]  U. Stein,et al.  Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate , 2005, Virchows Archiv A.

[35]  C. Morrissey,et al.  Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapies. , 2005, Clinical science.

[36]  Zang Ai-hua,et al.  Stem Cells,Cancer and Cancer Stem Cells , 2005 .

[37]  Massimo Loda,et al.  Fatty acid synthase: A metabolic oncogene in prostate cancer? , 2004, Journal of cellular biochemistry.

[38]  Zhong Jiang,et al.  Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: astudy of 761 cases. , 2003, Human pathology.